Home LiteratureArticle Details
PMID: 8035523 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures.

Journal of virology ·Vol. 68 ·No. 8 ·1994-08-00 ·Pages 5264-9

O'Brien WA, Mao SH, Cao Y, Moore JP

Abstract

Molecular clones of three macrophage-tropic and three T-cell line-adapted strains of human immunodeficiency virus type 1 (HIV-1) were used to explore the mechanism of HIV-1 resistance to neutralization by soluble CD4 (sCD4). The three macrophage-tropic viruses, each possessing the V3 and flanking regions of JR-FL, were all resistant to sCD4 neutralization under the standard conditions of a short preincubation of the virus and sCD4 at 37 degrees C prior to inoculation of peripheral blood mononuclear cells. In contrast, the three T-cell line-adapted viruses, NL4-3 and two chimeras possessing the V3 and flanking regions of NL4-3 in the envelope background of JR-FL, were all sCD4 sensitive under these conditions. Sensitivity to sCD4 neutralization at 37 degrees C corresponded with rapid, sCD4-induced gp120 shedding from the viruses. However, when the incubation temperature of the sCD4 and virus was reduced to 4 degrees C, the three macrophage-tropic viruses shed gp120 and became more sensitive to sCD4 neutralization. In contrast, the rates of sCD4-induced gp120 shedding and virus neutralization were reduced for the three T-cell line-adapted viruses at 4 degrees C. Thus, HIV resistance to sCD4 is a conditional phenomenon; macrophage-tropic and T-cell line-adapted strains can be distinguished by the temperature dependencies of their neutralization by sCD4. The average density of gp120 molecules on the macrophage-tropic viruses exceeded by about fourfold that on the T-cell line-adapted viruses, suggesting that HIV growth in T-cell lines may select for a destabilized envelope glycoprotein complex. Further studies of early events in HIV-1 infection should focus on primary virus strains.

MeSH Terms
Adaptation, Physiological CD4 Antigens/pharmacology HIV Envelope Protein gp120/metabolism HIV-1/physiology Humans Macrophages/microbiology Neutralization Tests Solubility T-Lymphocytes/microbiology Temperature
Chemicals
CD4 Antigens HIV Envelope Protein gp120
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
O'Brien W A
Department of Medicine, Veterans Affairs Medical Center, West Los Angeles, CA 90073.
Mao S H
Cao Y
Moore J P
References (31)
31 references, click to expand
  1. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
    J Virol. 1993 Feb;67(2):863-75 PMID: 7678308
  2. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    J Virol. 1992 Sep;66(9):5516-24 PMID: 1501286
  3. Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.
    J Virol. 1993 Mar;67(3):1461-71 PMID: 8437224
  4. Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4.
    AIDS Res Hum Retroviruses. 1993 Jun;9(6):529-39 PMID: 8347397
  5. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability.
    J Virol. 1993 Sep;67(9):5635-9 PMID: 8350416
  6. Jitters jeopardize AIDS vaccine trials.
    Science. 1993 Nov 12;262(5136):980-1 PMID: 8235635
  7. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype.
    J Infect Dis. 1994 Jan;169(1):48-54 PMID: 8277197
  8. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
    J Virol. 1994 Feb;68(2):1029-39 PMID: 7904656
  9. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.
    J Virol. 1994 Apr;68(4):2570-7 PMID: 8139036
  10. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  11. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.
    Science. 1987 May 15;236(4803):819-22 PMID: 3646751
  12. HIV infection is blocked in vitro by recombinant soluble CD4.
    Nature. 1988 Jan 7;331(6151):76-8 PMID: 2829022
  13. Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120.
    J Virol. 1989 Sep;63(9):3595-600 PMID: 2547987
  14. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574-8 PMID: 2395859
  15. Molecular targets for AIDS therapy.
    Science. 1990 Sep 28;249(4976):1533-44 PMID: 1699273
  16. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.
    Nature. 1990 Nov 1;348(6296):69-73 PMID: 2172833
  17. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  18. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
    Nature. 1991 Jan 10;349(6305):167-9 PMID: 1986308
  19. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3097-101 PMID: 2014229
  20. LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.
    Science. 1991 May 17;252(5008):961-5 PMID: 2035026
  21. Human immunodeficiency virus structure: implications for antiviral design.
    Adv Virus Res. 1991;39:1-87 PMID: 2038952
  22. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
    Science. 1991 Jul 5;253(5015):71-4 PMID: 1905842
  23. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.
    Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7056-60 PMID: 1871120
  24. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7802-5 PMID: 1909031
  25. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
    J Virol. 1992 Jan;66(1):235-43 PMID: 1727487
  26. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1335-9 PMID: 1741386
  27. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
    J Virol. 1992 Apr;66(4):2232-9 PMID: 1548759
  28. Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4.
    J Virol. 1992 May;66(5):3125-30 PMID: 1373203
  29. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.
    J Virol. 1992 Jul;66(7):4445-51 PMID: 1602552
  30. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.
    Science. 1992 Jul 24;257(5069):535-7 PMID: 1636088
  31. HIV tropism.
    Nature. 1993 Jan 28;361(6410):309-10 PMID: 8426650
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-08-00
Pages
5264-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC236471
Subset
IM
Grants
NIAID NIH HHS · AI 28697-03 · United States
NIAID NIH HHS · AI 29894-04 · United States
NIAID NIH HHS · AI27742-04 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com